VR Logo

Ipca Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1949

Chairman: Premchand Godha

Managing Director: Premchand Godha

Group: Ipca Laboratories

Listing: NSE: IPCALAB, BSE: 524494

Headquarters: Mumbai, Maharashtra

Website: www.ipcalabs.com

Key Facts

Market cap: R 21,001.62 Cr

Revenue (TTM): R 4,648.71 Cr

Earnings (TTM): R 611.39 Cr

Cash: R 372.68 Cr

Total Debt: R 464.95 Cr

Promoters' ownership: 46.07%

Liquidity: High

52 Week range: R 844.65 - 1,825.00

Face value: R2.00

Shares outstanding: 12,63,52,109

10 Years Aggregate:

  • CFO: 3,962.74 Cr
  • EBITDA: 4,642.41 Cr
  • Net Profit: 2,790.41 Cr

Stock Performance

Time Period Ipca Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD46.4823.40-10.50
1 month4.221.465.83
3 months3.8413.8617.78
1 Year74.9229.91-7.06
3 Years52.014.43-3.78
5 Years19.29-0.574.26
10 Years18.8111.156.23
As on 10-Jul-2020
Year Ipca Laboratories S&P BSE Mid Cap S&P BSE Healthcare
201939.19-3.05-3.55
201833.85-13.31-5.89
201712.2448.130.49
2016-28.197.97-12.88
20152.957.4315.06
20141.3254.6947.43
201338.06-5.7322.55